2018-2023 Global Remicade (infliximab) Drug Consumption Market Report

August 2018 | 137 pages | ID: 2CA948FF9FEEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Remicade (infliximab) Drug market for 2018-2023.
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.

Over the next five years, LPI(LP Information) projects that Remicade (infliximab) Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Remicade (infliximab) Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Brands Drugs
• Generic Drugs

Segmentation by application:

• Crohn's Disease
• Pediatric Crohn's Disease
• Ulcerative Colitis
• Pediatric Ulcerative Colitis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Janssen
• Hospira
• Celltrion Healthcare
• Epirus Biopharmaceuticals
• Samsung Bioepsis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Remicade (infliximab) Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Remicade (infliximab) Drug market by identifying its various subsegments.
• Focuses on the key global Remicade (infliximab) Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Remicade (infliximab) Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Remicade (infliximab) Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL REMICADE (INFLIXIMAB) DRUG CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Remicade (infliximab) Drug Consumption 2013-2023
  2.1.2 Remicade (infliximab) Drug Consumption CAGR by Region
2.2 Remicade (infliximab) Drug Segment by Type
  2.2.1 Brands Drugs
  2.2.2 Generic Drugs
2.3 Remicade (infliximab) Drug Consumption by Type
  2.3.1 Global Remicade (infliximab) Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Remicade (infliximab) Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Remicade (infliximab) Drug Sale Price by Type (2013-2018)
2.4 Remicade (infliximab) Drug Segment by Application
  2.4.1 Crohn's Disease
  2.4.2 Pediatric Crohn's Disease
  2.4.3 Ulcerative Colitis
  2.4.4 Pediatric Ulcerative Colitis
  2.4.5 Other
2.5 Remicade (infliximab) Drug Consumption by Application
  2.5.1 Global Remicade (infliximab) Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Remicade (infliximab) Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Remicade (infliximab) Drug Sale Price by Application (2013-2018)

3 GLOBAL REMICADE (INFLIXIMAB) DRUG BY PLAYERS

3.1 Global Remicade (infliximab) Drug Sales Market Share by Players
  3.1.1 Global Remicade (infliximab) Drug Sales by Players (2016-2018)
  3.1.2 Global Remicade (infliximab) Drug Sales Market Share by Players (2016-2018)
3.2 Global Remicade (infliximab) Drug Revenue Market Share by Players
  3.2.1 Global Remicade (infliximab) Drug Revenue by Players (2016-2018)
  3.2.2 Global Remicade (infliximab) Drug Revenue Market Share by Players (2016-2018)
3.3 Global Remicade (infliximab) Drug Sale Price by Players
3.4 Global Remicade (infliximab) Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Remicade (infliximab) Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Remicade (infliximab) Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 REMICADE (INFLIXIMAB) DRUG BY REGIONS

4.1 Remicade (infliximab) Drug by Regions
  4.1.1 Global Remicade (infliximab) Drug Consumption by Regions
  4.1.2 Global Remicade (infliximab) Drug Value by Regions
4.2 Americas Remicade (infliximab) Drug Consumption Growth
4.3 APAC Remicade (infliximab) Drug Consumption Growth
4.4 Europe Remicade (infliximab) Drug Consumption Growth
4.5 Middle East & Africa Remicade (infliximab) Drug Consumption Growth

5 AMERICAS

5.1 Americas Remicade (infliximab) Drug Consumption by Countries
  5.1.1 Americas Remicade (infliximab) Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Remicade (infliximab) Drug Value by Countries (2013-2018)
5.2 Americas Remicade (infliximab) Drug Consumption by Type
5.3 Americas Remicade (infliximab) Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Remicade (infliximab) Drug Consumption by Countries
  6.1.1 APAC Remicade (infliximab) Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Remicade (infliximab) Drug Value by Countries (2013-2018)
6.2 APAC Remicade (infliximab) Drug Consumption by Type
6.3 APAC Remicade (infliximab) Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Remicade (infliximab) Drug by Countries
  7.1.1 Europe Remicade (infliximab) Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Remicade (infliximab) Drug Value by Countries (2013-2018)
7.2 Europe Remicade (infliximab) Drug Consumption by Type
7.3 Europe Remicade (infliximab) Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Remicade (infliximab) Drug by Countries
  8.1.1 Middle East & Africa Remicade (infliximab) Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Remicade (infliximab) Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Remicade (infliximab) Drug Consumption by Type
8.3 Middle East & Africa Remicade (infliximab) Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Remicade (infliximab) Drug Distributors
10.3 Remicade (infliximab) Drug Customer

11 GLOBAL REMICADE (INFLIXIMAB) DRUG MARKET FORECAST

11.1 Global Remicade (infliximab) Drug Consumption Forecast (2018-2023)
11.2 Global Remicade (infliximab) Drug Forecast by Regions
  11.2.1 Global Remicade (infliximab) Drug Forecast by Regions (2018-2023)
  11.2.2 Global Remicade (infliximab) Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Remicade (infliximab) Drug Forecast by Type
11.8 Global Remicade (infliximab) Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Janssen
  12.1.1 Company Details
  12.1.2 Remicade (infliximab) Drug Product Offered
  12.1.3 Janssen Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Janssen News
12.2 Hospira
  12.2.1 Company Details
  12.2.2 Remicade (infliximab) Drug Product Offered
  12.2.3 Hospira Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Hospira News
12.3 Celltrion Healthcare
  12.3.1 Company Details
  12.3.2 Remicade (infliximab) Drug Product Offered
  12.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Celltrion Healthcare News
12.4 Epirus Biopharmaceuticals
  12.4.1 Company Details
  12.4.2 Remicade (infliximab) Drug Product Offered
  12.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Epirus Biopharmaceuticals News
12.5 Samsung Bioepsis
  12.5.1 Company Details
  12.5.2 Remicade (infliximab) Drug Product Offered
  12.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Samsung Bioepsis News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Remicade (infliximab) Drug
Table Product Specifications of Remicade (infliximab) Drug
Figure Remicade (infliximab) Drug Report Years Considered
Figure Market Research Methodology
Figure Global Remicade (infliximab) Drug Consumption Growth Rate 2013-2023 (K Units)
Figure Global Remicade (infliximab) Drug Value Growth Rate 2013-2023 ($ Millions)
Table Remicade (infliximab) Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Brands Drugs
Table Major Players of Brands Drugs
Figure Product Picture of Generic Drugs
Table Major Players of Generic Drugs
Table Global Consumption Sales by Type (2013-2018)
Table Global Remicade (infliximab) Drug Consumption Market Share by Type (2013-2018)
Figure Global Remicade (infliximab) Drug Consumption Market Share by Type (2013-2018)
Table Global Remicade (infliximab) Drug Revenue by Type (2013-2018) ($ million)
Table Global Remicade (infliximab) Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Remicade (infliximab) Drug Value Market Share by Type (2013-2018)
Table Global Remicade (infliximab) Drug Sale Price by Type (2013-2018)
Figure Remicade (infliximab) Drug Consumed in Crohn's Disease
Figure Global Remicade (infliximab) Drug Market: Crohn's Disease (2013-2018) (K Units)
Figure Global Remicade (infliximab) Drug Market: Crohn's Disease (2013-2018) ($ Millions)
Figure Global Crohn's Disease YoY Growth ($ Millions)
Figure Remicade (infliximab) Drug Consumed in Pediatric Crohn's Disease
Figure Global Remicade (infliximab) Drug Market: Pediatric Crohn's Disease (2013-2018) (K Units)
Figure Global Remicade (infliximab) Drug Market: Pediatric Crohn's Disease (2013-2018) ($ Millions)
Figure Global Pediatric Crohn's Disease YoY Growth ($ Millions)
Figure Remicade (infliximab) Drug Consumed in Ulcerative Colitis
Figure Global Remicade (infliximab) Drug Market: Ulcerative Colitis (2013-2018) (K Units)
Figure Global Remicade (infliximab) Drug Market: Ulcerative Colitis (2013-2018) ($ Millions)
Figure Global Ulcerative Colitis YoY Growth ($ Millions)
Figure Remicade (infliximab) Drug Consumed in Pediatric Ulcerative Colitis
Figure Global Remicade (infliximab) Drug Market: Pediatric Ulcerative Colitis (2013-2018) (K Units)
Figure Global Remicade (infliximab) Drug Market: Pediatric Ulcerative Colitis (2013-2018) ($ Millions)
Figure Global Pediatric Ulcerative Colitis YoY Growth ($ Millions)
Figure Remicade (infliximab) Drug Consumed in Other
Figure Global Remicade (infliximab) Drug Market: Other (2013-2018) (K Units)
Figure Global Remicade (infliximab) Drug Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Remicade (infliximab) Drug Consumption Market Share by Application (2013-2018)
Figure Global Remicade (infliximab) Drug Consumption Market Share by Application (2013-2018)
Table Global Remicade (infliximab) Drug Value by Application (2013-2018)
Table Global Remicade (infliximab) Drug Value Market Share by Application (2013-2018)
Figure Global Remicade (infliximab) Drug Value Market Share by Application (2013-2018)
Table Global Remicade (infliximab) Drug Sale Price by Application (2013-2018)
Table Global Remicade (infliximab) Drug Sales by Players (2016-2018) (K Units)
Table Global Remicade (infliximab) Drug Sales Market Share by Players (2016-2018)
Figure Global Remicade (infliximab) Drug Sales Market Share by Players in 2016
Figure Global Remicade (infliximab) Drug Sales Market Share by Players in 2017
Table Global Remicade (infliximab) Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Remicade (infliximab) Drug Revenue Market Share by Players (2016-2018)
Figure Global Remicade (infliximab) Drug Revenue Market Share by Players in 2016
Figure Global Remicade (infliximab) Drug Revenue Market Share by Players in 2017
Table Global Remicade (infliximab) Drug Sale Price by Players (2016-2018)
Figure Global Remicade (infliximab) Drug Sale Price by Players in 2017
Table Global Remicade (infliximab) Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Remicade (infliximab) Drug Products Offered
Table Remicade (infliximab) Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Remicade (infliximab) Drug Consumption by Regions 2013-2018 (K Units)
Table Global Remicade (infliximab) Drug Consumption Market Share by Regions 2013-2018
Figure Global Remicade (infliximab) Drug Consumption Market Share by Regions 2013-2018
Table Global Remicade (infliximab) Drug Value by Regions 2013-2018 ($ Millions)
Table Global Remicade (infliximab) Drug Value Market Share by Regions 2013-2018
Figure Global Remicade (infliximab) Drug Value Market Share by Regions 2013-2018
Figure Americas Remicade (infliximab) Drug Consumption 2013-2018 (K Units)
Figure Americas Remicade (infliximab) Drug Value 2013-2018 ($ Millions)
Figure APAC Remicade (infliximab) Drug Consumption 2013-2018 (K Units)
Figure APAC Remicade (infliximab) Drug Value 2013-2018 ($ Millions)
Figure Europe Remicade (infliximab) Drug Consumption 2013-2018 (K Units)
Figure Europe Remicade (infliximab) Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Remicade (infliximab) Drug Consumption 2013-2018 (K Units)
Figure Middle East & Africa Remicade (infliximab) Drug Value 2013-2018 ($ Millions)
Table Americas Remicade (infliximab) Drug Consumption by Countries (2013-2018) (K Units)
Table Americas Remicade (infliximab) Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Remicade (infliximab) Drug Consumption Market Share by Countries in 2017
Table Americas Remicade (infliximab) Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Remicade (infliximab) Drug Value Market Share by Countries (2013-2018)
Figure Americas Remicade (infliximab) Drug Value Market Share by Countries in 2017
Table Americas Remicade (infliximab) Drug Consumption by Type (2013-2018) (K Units)
Table Americas Remicade (infliximab) Drug Consumption Market Share by Type (2013-2018)
Figure Americas Remicade (infliximab) Drug Consumption Market Share by Type in 2017
Table Americas Remicade (infliximab) Drug Consumption by Application (2013-2018) (K Units)
Table Americas Remicade (infliximab) Drug Consumption Market Share by Application (2013-2018)
Figure Americas Remicade (infliximab) Drug Consumption Market Share by Application in 2017
Figure United States Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure United States Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Canada Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Mexico Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Table APAC Remicade (infliximab) Drug Consumption by Countries (2013-2018) (K Units)
Table APAC Remicade (infliximab) Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Remicade (infliximab) Drug Consumption Market Share by Countries in 2017
Table APAC Remicade (infliximab) Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Remicade (infliximab) Drug Value Market Share by Countries (2013-2018)
Figure APAC Remicade (infliximab) Drug Value Market Share by Countries in 2017
Table APAC Remicade (infliximab) Drug Consumption by Type (2013-2018) (K Units)
Table APAC Remicade (infliximab) Drug Consumption Market Share by Type (2013-2018)
Figure APAC Remicade (infliximab) Drug Consumption Market Share by Type in 2017
Table APAC Remicade (infliximab) Drug Consumption by Application (2013-2018) (K Units)
Table APAC Remicade (infliximab) Drug Consumption Market Share by Application (2013-2018)
Figure APAC Remicade (infliximab) Drug Consumption Market Share by Application in 2017
Figure China Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure China Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Japan Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Korea Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure India Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure India Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Australia Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Table Europe Remicade (infliximab) Drug Consumption by Countries (2013-2018) (K Units)
Table Europe Remicade (infliximab) Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Remicade (infliximab) Drug Consumption Market Share by Countries in 2017
Table Europe Remicade (infliximab) Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Remicade (infliximab) Drug Value Market Share by Countries (2013-2018)
Figure Europe Remicade (infliximab) Drug Value Market Share by Countries in 2017
Table Europe Remicade (infliximab) Drug Consumption by Type (2013-2018) (K Units)
Table Europe Remicade (infliximab) Drug Consumption Market Share by Type (2013-2018)
Figure Europe Remicade (infliximab) Drug Consumption Market Share by Type in 2017
Table Europe Remicade (infliximab) Drug Consumption by Application (2013-2018) (K Units)
Table Europe Remicade (infliximab) Drug Consumption Market Share by Application (2013-2018)
Figure Europe Remicade (infliximab) Drug Consumption Market Share by Application in 2017
Figure Germany Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Germany Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure France Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure France Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure UK Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure UK Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Italy Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Russia Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Spain Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Remicade (infliximab) Drug Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Remicade (infliximab) Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Remicade (infliximab) Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Remicade (infliximab) Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Remicade (infliximab) Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Remicade (infliximab) Drug Value Market Share by Countries in 2017
Table Middle East & Africa Remicade (infliximab) Drug Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Remicade (infliximab) Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Remicade (infliximab) Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Remicade (infliximab) Drug Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Remicade (infliximab) Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Remicade (infliximab) Drug Consumption Market Share by Application in 2017
Figure Egypt Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Egypt Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure South Africa Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Israel Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure Turkey Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Remicade (infliximab) Drug Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Remicade (infliximab) Drug Value Growth 2013-2018 ($ Millions)
Table Remicade (infliximab) Drug Distributors List
Table Remicade (infliximab) Drug Customer List
Figure Global Remicade (infliximab) Drug Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Remicade (infliximab) Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Remicade (infliximab) Drug Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Remicade (infliximab) Drug Consumption Market Forecast by Regions
Table Global Remicade (infliximab) Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Remicade (infliximab) Drug Value Market Share Forecast by Regions
Figure Americas Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Americas Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure APAC Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure APAC Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Europe Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Europe Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Middle East & Africa Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure United States Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure United States Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Canada Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Canada Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Mexico Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Mexico Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Brazil Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Brazil Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure China Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure China Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Japan Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Japan Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Korea Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Korea Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure India Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure India Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Australia Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Australia Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Germany Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Germany Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure France Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure France Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure UK Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure UK Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Italy Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Italy Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Russia Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Russia Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Spain Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Spain Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Egypt Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Egypt Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure South Africa Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure South Africa Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Israel Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Israel Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure Turkey Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure Turkey Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Remicade (infliximab) Drug Consumption 2018-2023 (K Units)
Figure GCC Countries Remicade (infliximab) Drug Value 2018-2023 ($ Millions)
Table Global Remicade (infliximab) Drug Consumption Forecast by Type (2018-2023) (K Units)
Table Global Remicade (infliximab) Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Remicade (infliximab) Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Remicade (infliximab) Drug Value Market Share Forecast by Type (2018-2023)
Table Global Remicade (infliximab) Drug Consumption Forecast by Application (2018-2023) (K Units)
Table Global Remicade (infliximab) Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Remicade (infliximab) Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Remicade (infliximab) Drug Value Market Share Forecast by Application (2018-2023)
Table Janssen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Janssen Remicade (infliximab) Drug Market Share (2016-2018)
Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hospira Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hospira Remicade (infliximab) Drug Market Share (2016-2018)
Table Celltrion Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Healthcare Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celltrion Healthcare Remicade (infliximab) Drug Market Share (2016-2018)
Table Epirus Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Epirus Biopharmaceuticals Remicade (infliximab) Drug Market Share (2016-2018)
Table Samsung Bioepsis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samsung Bioepsis Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Samsung Bioepsis Remicade (infliximab) Drug Market Share (2016-2018)